Article about HIV diagnoses among American Indian/Alaska Natives; identifies current rates and trends to support data-driven policy implementation and resource allocation. […]
Type: Website
Indian Health Service – HIV Clinical Resources (IHS)
Useful HIV clinical resources provided by the Indian Health Service. […]
Read More… from Indian Health Service – HIV Clinical Resources (IHS)
HIV Clinical Guidelines (NIH)
Federally approved medical practice guidelines for HIV/AIDS developed by panels of experts in HIV care. […]
Interim Guidance for COVID-19 and Persons with HIV (NIH)
This interim guidance reviews special considerations for persons with HIV and their health care providers in the United States regarding COVID-19. […]
Read More… from Interim Guidance for COVID-19 and Persons with HIV (NIH)
Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants (SAMHSA)
Comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. […]
Guide for Appropriate Tapering or Discontinuation of Long-Term Opioid Use (HHS)
Guidance for providers when changing a patientâs chronic pain therapy. […]
Read More… from Guide for Appropriate Tapering or Discontinuation of Long-Term Opioid Use (HHS)
Top Seven Telehealth Privacy Considerations for SUD Treatment and Recovery Support Providers (CoE-PHI)
8-Part podcast series focusing on tips and resources for SUD and recovery support treatment providers on the topic of maintaining patient privacy while providing telehealth services. […]
Rx Pain Medications, Know the Options, Get the Facts – Prescription Drug Monitoring Programs (SAMHSA)
Fact sheet that focuses on how Prescription Drug Monitoring Programs (PDMPs) help health providers better serve their patients’ needs and promote safety. […]
Practitioner Training (SAMHSA)
Tools, training, and technical assistance for practitioners in the field of substance use and mental health disorders. […]
Steps to Obtain your MAT Waiver (PCSS)
Guidance for obtaining waiver (required by the DEA) for the use of buprenorphine in medication-assisted treatment. […]



















































































